This paper is devoted to an actual problem in cardiology and endocrinology, a problem of combined interaction of myocardial infarction and diabetes mellitus, which represent a serious medical and social significance. It is noted that fatal myocardial infarction in patients with diabetes mellitus is significantly higher than in patients without diabetes, regardless of the time of follow-up period. The authors note the importance of improvement the efficiency of complex treatment of acute myocardial infarction by correction of metabolic, blood rheological and microcirculatory parameters in patients with diabetes mellitus in combination with the total myocardial revascularization. This article highlights the epidemiology of diabetes mellitus, pathogenesis of myocardial infarction in patients with diabetes mellitus. The authors represent modern ideas of microcirculation disorders and pathophysiology of atherosclerosis and diabetes mellitus. Based on the pathophysiological model of diabetes, the authors reflect current approaches to the treatment of acute myocardial infarction. In con-clusion, the authors emphasize the need for an integrated approach to optimize the treatment algorithms and prognosis of myocardial infarction in patients with diabetes mellitus, to improve the nearest and long-term re-sults of percutaneous coronary intervention and coronary artery bypass grafting by the correction of metabolic disorders, blood rheology and lipid peroxidation.
diabetes mellitus, acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery.
1. Azarov A. A., Evtushenko S. A., Tavlueva E. V., Barbarash O. L. Otdalennye rezul´taty endova-skulyarnykh vmeshatel´stv u patsientov s ostrym infarktom miokarda v sochetanii s sakharnym diabetom 2 tipa. Materialy vserossiyskoy nauchno-prakticheskoy konferentsii «Obliteriruyushchie zabolevaniya sosudov: problemy i perspektivy». Kemerovo, 2009. S. 20-21.
2. Vatutin M.K. Miokardial´naya tsitoprotektsiya i inotropnaya stimulyatsiya u bol´nykh in-farktom miokarda s pod´´emom segmenta ST, oslozhnennym serdechnoy nedostatochnost´yu: Avtoref. diss. kand. med. nauk. Kemerovo, 2013. 25 s.
3. Voznesenskiy N.K., Slobozhlninova E.V. Dinamika pokazateley svobodnoradikal´nogo okis-leniya lipidov i antioksidantnoy aktivnosti pri lechenii ostrykh koronarnykh sindromov bez pod´´emov ST s ispol´zovaniem preparatov yantarnoy kisloty. Nizhegorodskiy meditsinskiy zhurnal. 2004. № 3. S. 60-65.
4. Dedov I.I., Shestakova M.V., Galstyan G.R. Algoritmy spetsializirovannoy meditsinskoy po-moshchi bol´nym sakharnym diabetom. Sakharnyy diabet. 2015. T.18, №1S. S. 1-112.
5. Demidova T.Yu. Ateroskleroz i sakharnyy diabet tipa 2: mekhanizmy i upravlenie. Cardio So-matika. 2011. №2. S. 22-30.
6. Kakorin S.V., Karamyshev D.V., Mkrtumyan A.M. Ostryy infarkt miokarda u bol´nykh sakhar-nym diabetom 2-go tipa. Serdtse. 2010. №2. S. 97-101.
7. Klypa T.V., Orekhova M.S., Zabrosaeva L.I. Giperglikemiya kriticheskikh sostoyaniy. Sakharnyy diabet. 2015. №1. S. 33-41.
8. Mironkov A.B., Abugov S.A. Movsesyants M.Yu. Pervichnoe chreskozhnoe koronarnoe vmeshatel´-stvo s vypolneniem profilaktiki mikrotsirkulyatornoy embolii: rezul´taty gospital´no-go i otdalen-nogo periodov nablyudeniya. Kardiologiya i serdechno-sosudistaya khirurgiya. 2012.T. 5, №4. S. 13-17.
9. Oynotkinova O.Sh. Rol´ svobodnoradikal´nogo okisleniya lipidov i fermentov antioksi-dantnoy zashchity v prognoze infarkta miokarda u bol´nykh INSD. Kardiovaskulyarnaya terapiya i pro-filaktika (prilozhenie). 2010. № 4. S. 34.
10. Oynotkinova O.Sh., Nikulin A.I., Belyakin S.A., Shklovskiy B.L. Znachenie gemoreologicheskikh i transkapillyarnykh narusheniy pri ostrom koronarnom sindrome. Vestnik rossiyskoy voenno-meditsinskoy akademii. 2009. T. 26, № 2. S. 16-22.
11. Panova E.I., Strongin L.G., Kruglova N.E. Osobennosti infarkta miokarda pri sakharnom diabete 2 tipa v zavisimosti ot urovnya glikozilirovannogo gemoglobina. Nizhegorodskiy meditsin-skiy zhurnal. 2006. №3. S. 6-8.
12. Samoylova (Kalugina) O.Yu., Nosov V.P. Otdalennye rezul´taty endovaskulyarnogo lecheniya u patsientov s ishemicheskoy bolezn´yu serdtsa v sochetanii s sakharnym diabetom 2 tipa. Sovremennye problemy nauki i obrazovaniya. 2014. № 5. S. 480.
13. Sokolov E.I. Diabeticheskoe serdtse. M.: Meditsina, 2002. 416 s.
14. Strongin L.G., Panova E.I., Belyaeva N.G. Effektivnost´ strogogo glikemicheskogo kontrolya v pervye 24 ch ostrogo perioda infarkta miokarda u bol´nykh sakharnym diabetom 2-go tipa . Kardiolo-giya. 2009. T. 49, №11. S. 17-21.
15. Tavlueva E.V., Usol´tseva E. N., Barbarash O. L. Mediatory sistemnogo vospaleniya u bol´nykh infarktom miokarda s pod´´emom segmenta ST i s sakharnym diabetom 2-go tipa. Materialy Vserossiyskoy nauchno-prakticheskoy konferentsii, posvyashchennoy 20-letiyu Kuzbasskogo kardiologicheskogo tsentra. Kemerovo, 2010. S. 268-269.
16. Ulyatovskiy V.A., Filippov A.E., Nikitin A.E. Farmakologicheskaya korrektsiya rasstroystv mikrotsirkulyatsii i vnutriserdechnoy gemodinamiki. Vestnik Rossiyskoy Voenno-meditsinskoy akade-mii. 2010. Pril. №2 (30). S. 92-100.
17. Erlikh A.D., Gratsianskiy N.A. Ostryy koronarnyy sindrom u bol´nykh sakharnym diabetom. Dannye registra REKORD. Kardiologiya. 2011. T. 51, №11. S. 16-21.
18. American Diabetes Asosiation. Approaches to Glycemic Treatment.. Diabetes care. 2015. 38(Supplement 1). S41-S48.
19. Antonio N., Fernandes R., Soares A. Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. Cardiovascular diabetology. 2014. V. 13. R. 101.
20. Badawi O., Waite M.D., Fuhrman S.A., Zuckerman I.H. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Critical care medicine. 2012. 40(12). R. 3180-3188.
21. Barbukhatti K., Belash S., Boldyrev S. Coronary artery bypass graft surgery in patient with acute co-ronary syndrome: 5 years experience. Interactive Cardio Vascular and Thoracic Surgery. 2009. Vol. 8 (suppl). P. S33.
22. Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAP-CI). European journal of cardio-thoracic surgery. 2014. 46(4). R. 517-592.
23. Inzucchi S.E., Zinman B., Wanner C. SGLT-2 inhibitors and cardiovascular risk: Proposed pathwys and review of ongoing outcome trials. Diabetes & vascular disease research. 2015. 12(2). R. 90-100.
24. Kolh P., Windecker S., Alfonso F. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Zhao CT, Wang M, Siu CW, et al. Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxida-tive stress. Cardiovascular diabetology. 2012. V. 11. R. 147.
25. Krolewski A.S., Laffel L.M.B., Krolewski M., Quinn M., Warram J.H. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulindependent diabetes mellitus. N. Engl. J. Med. 1995. V. 332. R. 1251-1255.
26. Lorber D. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab. Syndr. Obes. 2014. V. 7. P. 169-183.
27. Marfella R., Sasso F.C., Cacciapuoti F. Tight glycemic control may increase regenerative potential of myocardium during acute infarction . The Journal of Clinical Endocrinology & Metabolism. 2011. V. 97(3). R. 933-942.
28. Papak J., Kansagara D. Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease. The American journal of cardiology. 2012. 110(9 Suppl). R. 24B-31B.
29. Scott R., Anderson J.L., Adams C.D., Bridges C.R., Casey D.E., Ettinger S.M. 2011 ACCF/AHA Fo-cused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myo-cardial Infarction (Updating the 2007 Guideline). Journal of the American College of Cardiology. 2011. 57(19). R. 1920-1959.
30. Standards of Medical Care in Diabetes-2015.. Diabetes Care. 2015. 38(Supplement 1). R. S1-S93.
